#generic-drugs
Brazil Clears First Generic Copy of Novo Nordisk’s Ozempic Shot
Brazil approved the country’s first generic version of Novo Nordisk A/S’s Ozempic shot, opening the door to cheaper competition in one of the world’s fastest-growing markets for weight loss and diabetes drugs.
Generic Ozempic is now on Canadian shelves. Is it the same as the brand name version?
Some Canadian pharmacists are already stocking their shelves with generic versions of semaglutide, more commonly known by the brand name Ozempic. But will these generics be just as good, and how much will the cost come down?
Weight-loss drug semaglutide set to get cheaper as generic wave builds in India
Prices for generic semaglutide, a popular weight-loss drug, are expected to fall by more than half in the coming months. This sharp decline is anticipated with the entry of smaller brands and a significant drop in raw material costs. The cost for a month's do…
When will cheaper generic Ozempic arrive? #health
Timeline for generic Ozempic in the U.S. Cheaper generic versions of Ozempic are moving through other markets first, but the United States timeline is still unclear based on the coverage provided. One report states that India already has a generic version , a…
Cheaper generic Ozempic is coming soon — but not for Americans
India got it earlier this year, and Canada approved it last month. But when is the United States going to get a generic version of Ozempic?
Dr. Reddy's to launch generic Ozempic in Canada within days
Dr Reddy’s Laboratories Ltd. plans to launch its version of generic Ozempic this month, filling a void in the Canadian market. Read here
Novo Sees Generic Ozempic Delayed in China Until Next Year
Novo Nordisk A/S expects generic Ozempic to be delayed in China until next year, a positive step for the drugmaker as it battles to keep its share of the global obesity market.
Ibuprofen API Market to Reach USD 1.12 Billion by 2035 Driven by Expanding Generic Drug Manufacturing and OTC Demand | SNS Insider
U.S. Ibuprofen API Market to Reach USD 0.22 Billion by 2035 Driven by Rising OTC Pain Medication Demand U.S. Ibuprofen API Market to Reach USD 0.22 Billion by 2035 Driven by Rising OTC Pain Medication Demand
OneSource notches a second generic semaglutide approval in Canada, through partner
The generic version of Ozempic from Canadian-based Apotex, has been approved, Health Canada said, adding that it was the second generic approved, even as seven applications were being reviewed
Canada Just Got Generic Ozempic. Americans Shouldn’t Hold Their Breath
It'll probably take several years before generic semaglutide could arrive stateside.